Latest news with #EmeritaMichiko
4 days ago
- Health
Japan Emperor Emeritus Found with Another Heart Disorder
News from Japan Society Jul 18, 2025 19:33 (JST) Tokyo, July 18 (Jiji Press)--Japan's Emperor Emeritus Akihito was confirmed Friday to be suffering from supraventricular arrhythmia, according to an aide. The 91-year-old former Emperor was discharged from the University of Tokyo Hospital the same day, after he began receiving an additional oral treatment for his heart during his hospitalization. He will refrain from exercise that puts heavy burdens on the heart, such as using stairs. Emperor Emeritus Akihito, accompanied by Empress Emerita Michiko, 90, left the hospital in Tokyo's Bunkyo Ward by car around 11:30 a.m. and returned to the Sento Imperial Residence in the Japanese capital's Minato Ward. He began taking the oral medication to ease the load on his heart from asymptomatic myocardial ischemia, which was identified this May. The treatment did not cause side effects such as bradycardia or arrhythmia. [Copyright The Jiji Press, Ltd.] Jiji Press
Yomiuri Shimbun
4 days ago
- Health
- Yomiuri Shimbun
Japan's Emperor Emeritus Leaves Hospital after Heart Treatment
Tokyo, July 18 (Jiji Press) — Japan's Emperor Emeritus Akihito was discharged from the University of Tokyo Hospital on Friday after receiving an additional oral treatment for his heart. The 91-year-old former Emperor, accompanied by Empress Emerita Michiko, 90, left the hospital in Tokyo's Bunkyo Ward by car around 11:30 a.m. and headed for their residence, the Sento Imperial Residence in the Japanese capital's Minato Ward. In 2022, the Emperor Emeritus was diagnosed with right heart failure caused by tricuspid valve insufficiency. He was admitted to the university hospital in May for a heart examination and diagnosed with asymptomatic myocardial ischemia. After being discharged from the hospital, he was treated with medication to improve blood flow. As there was no improvement, however, the medical team determined that he needed the additional oral medication to ease the load on his heart. He had been hospitalized since Monday for dosage adjustment.
4 days ago
- Health
Japan's Emperor Emeritus Leaves Hospital after Heart Treatment
News from Japan Society Jul 18, 2025 12:50 (JST) Tokyo, July 18 (Jiji Press)--Japan's Emperor Emeritus Akihito was discharged from the University of Tokyo Hospital on Friday after receiving an additional oral treatment for his heart. The 91-year-old former Emperor, accompanied by Empress Emerita Michiko, 90, left the hospital in Tokyo's Bunkyo Ward by car around 11:30 a.m. and headed for their residence, the Sento Imperial Residence in the Japanese capital's Minato Ward. In 2022, the Emperor Emeritus was diagnosed with right heart failure caused by tricuspid valve insufficiency. He was admitted to the university hospital in May for a heart examination and diagnosed with asymptomatic myocardial ischemia. After being discharged from the hospital, he was treated with medication to improve blood flow. As there was no improvement, however, the medical team determined that he needed the additional oral medication to ease the load on his heart. He had been hospitalized since Monday for dosage adjustment. END [Copyright The Jiji Press, Ltd.] Jiji Press
Japan Today
14-07-2025
- Health
- Japan Today
Emperor Emeritus Akihito hospitalized to adjust his heart medication
Emperor Emeritus Akihito and Empress Emerita Michiko pose for a photograph at their residence in Tokyo on Oct 4, 2024. Emperor Emeritus Akihito, 91, was hospitalized Monday to adjust his heart medication, palace officials said. Akihito was diagnosed in May with myocardial ischemia, an asymptomatic heart condition of reduced blood flow from the coronary arteries to the heart muscle. He has since been on medication to improve blood flow to his heart while avoiding excessive exercise and reducing liquid intake. Akihito abdicated in 2019, handing over the Chrysanthemum Throne to his son, current Emperor Naruhito. After two months on the medication, doctors found little improvement in Akihito's condition and decided to give him an additional treatment to alleviate the burden on his heart, the Imperial Household Agency said. Monday's hospitalization was to carefully determine the right dose of the new medication to avoid side effects, while monitoring his heart by electrocardiogram and other examination, the IHA said. In 2012, Akihito underwent a coronary artery bypass surgery. Three years ago, he was diagnosed with right heart failure caused by tricuspid valve insufficiency. Akihito was seen in the back seat of a palace car, wearing a white surgical mask and accompanied by his wife, Empress Emerita Michiko, as he was taken to the hospital. Palace officials said they couldn't say how long Akihito would have to be hospitalized. © Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
14-07-2025
- Health
Japan's Emperor Emeritus Hospitalized for Further Treatment
News from Japan Society Jul 14, 2025 17:20 (JST) Tokyo, July 14 (Jiji Press)--Japan's Emperor Emeritus Akihito was admitted to the University of Tokyo Hospital on Monday afternoon to begin an additional oral treatment for his heart. The hospital will decide the amount of medication the 91-year-old former Emperor will receive, while assessing the results of his electrocardiogram and other tests. The Emperor Emeritus arrived at the hospital in Tokyo's Bunkyo Ward at around 3:30 p.m. after leaving the Sento Imperial Residence in the Japanese capital's Minato Ward in a vehicle, accompanied by his 90-year-old wife, Empress Emerita Michiko. In July 2022, the Emperor Emeritus was diagnosed with right heart failure caused by tricuspid valve insufficiency. He was admitted to the university hospital in May for a heart examination and diagnosed with asymptomatic myocardial ischemia. According to his aides, the Emperor Emeritus has carried out low-strain exercises and walks to maintain his health since the May hospitalization. He also began taking medication to improve coronary artery blood flow. [Copyright The Jiji Press, Ltd.] Jiji Press
